Cargando...

LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

RTTNews | hace 652

LAVA Therapeutics Appoints Dr. Charles Morris As Chief Medical Officer

(RTTNews) - Immuno-oncology company LAVA Therapeutics N.V. (LVTX) announced Monday that Dr. Charles Morris has joined LAVA as chief medical officer effective February 6, 2023. Dr. Morris will replace Benjamin Winograd.

Dr. Morris is a medical oncologist with over 25 years of oncology drug development experience working with global biotech and pharmaceutical companies and managing numerous drug approvals.

Most recently, he was the chief medical officer for biotechnology company Celyad Oncology. He also served as chief medical officer of Radius Health and held leadership positions at PsiOxus Therapeutics, ImmunoGen and Allos Therapeutics.

He was also vice president of worldwide clinical research at Cephalon where he supported the approval of TREANDA (bendamustine) for the treatment of indolent non-Hodgkin lymphoma and chronic lymphocytopenia.

He began his career at AstraZeneca and held roles of increasing responsibility including global medical lead for Faslodex (fulvestrant) which he managed through its approval for breast cancer.

Tags: LVTX

read more

Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

Seagen Inc. (SGEN), a pioneer in antibody-drug conjugate (ADC) therapies, and LAVA Therapeutics N.V. (LVTX), a clinical-stage immuno-oncology company, announced Monday an exclusive license agreement in which Seagen will work to develop, manufacture and commercialize LAVA-1223.

RTTNews | hace 785

U.S. Housing Starts Tumble 3.1% In October, More Than Expected

U.S. Housing Starts Tumble 3.1% In October, More Than Expected

New residential construction in the U.S. tumbled by more than expected in the month of October, according to a report released by the Commerce Department on Tuesday. The report said housing starts dove by 3.1 percent to an annual rate of 1.311 million in October after slumping by 1.9 percent to a revised rate of 1.353 million in September.

RTTNews | hace 7h 6min

U.S. Housing Starts Tumble More Than Expected In October

U.S. Housing Starts Tumble More Than Expected In October

New residential construction in the U.S. tumbled by more than expected in the month of October, according to a report released by the Commerce Department on Tuesday.

RTTNews | hace 8h 4min

Eurozone Inflation Rises To 2% As Estimated

Eurozone Inflation Rises To 2% As Estimated

Eurozone inflation returned to the 2 percent target in October, final data from Eurostat showed on Tuesday. The harmonized index of consumer prices climbed as initially estimated in October after rising 1.7 percent in September. Core inflation that excludes prices of energy, food, alcohol and tobacco, remained unchanged at 2.7 percent in October.

RTTNews | hace 8h 24min

Bay Street Seen Opening Lower On Geopolitical Concerns; Canadian Inflation Data In Focus

Bay Street Seen Opening Lower On Geopolitical Concerns; Canadian Inflation Data In Focus

Canadian shares look headed for a weak start on Tuesday amid rising geopolitical concerns after Russian President Vladimir Putin updated nuclear doctrine.

RTTNews | hace 8h 48min

Euro Slides Against Majors

Euro Slides Against Majors

The euro weakened against other major currencies in the European session on Tuesday, as traders are worried that protectionist policies by President-elected Donald Trump could disrupt the Eurozone's growth potential.

RTTNews | hace 8h 54min

FTSE 100 Slips As Geopolitics Weighs

FTSE 100 Slips As Geopolitics Weighs

The FTSE 100 benchmark of the London Stock Exchange aligned with the trend in European markets to trade in the red amidst a massive spike in geopolitical concerns. However, the index managed to outperform its European peers.

RTTNews | hace 8h 58min

European Stocks Tumble As Russia-Ukraine War Hurts Sentiment

European Stocks Tumble As Russia-Ukraine War Hurts Sentiment

European stocks are reeling under a bout of selling pressure on Tuesday following an escalation in the Russia - Ukraine war, and amid uncertainty about U.S. interest-rate trajectory and the outlook for global economic growth.

RTTNews | hace 9h 7min

Condiciones | Privacidad | Mapa del sitio | Site Map Calendar

© 2024 Myfxbook Ltd. Todos los Derechos Reservados.

ADVERTENCIA DE ALTO RIESGO: El comercio de divisas implica un alto nivel de riesgo que puede no ser adecuado para todos los inversores. El efecto de apalancamiento crea un riesgo adicional y una exposición a las pérdidas. Antes de decidirse a operar con divisas, considere cuidadosamente sus objetivos de inversión, su nivel de experiencia y su tolerancia al riesgo. Podría perder una parte o la totalidad de su inversión inicial. No invierta dinero que no puede permitirse perder. Infórmese sobre los riesgos asociados al trading de divisas y pida consejo a un asesor financiero o fiscal independiente si tiene alguna duda. Todos los datos y la información se proporcionan "tal cual" con fines informativos únicamente y no están destinados a fines comerciales o de recomendación. Los resultados pasados no son indicativos de los resultados futuros.